BusinessWellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 DiabetesBy Nasdaq OMXApr 3, 2018, 1:01 PM UTC
BusinessSolera Health and WellDoc Partner to Offer Health Plans and Employers a Holistic Approach to Diabetes Prevention and ManagementBy Nasdaq OMXJan 17, 2018, 3:00 PM UTC
BusinessVoluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic OfferingsBy Nasdaq OMXJan 9, 2018, 2:02 PM UTC
BusinessWellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare CostsBy Nasdaq OMXJan 4, 2018, 2:00 PM UTC
BusinessIQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes TreatmentBy Nasdaq OMXNov 13, 2017, 3:52 PM UTC
BusinessNEBGH President & CEO Laurel Pickering to Join Leading Digital Health Company, WellDoc, as Chief Revenue OfficerBy Nasdaq OMXOct 3, 2017, 1:00 PM UTC
BusinessUPDATE -- WellDoc Diabetes Thought Leaders Publish Article Highlighting Need for Integration of Digital Health Tools into Diabetes Educators’ PracticesBy Nasdaq OMXAug 28, 2017, 1:48 PM UTC
BusinessFor Immediate Release WellDoc Diabetes Thought Leaders Publish Article Highlighting Need for Integration of Digital Health Tools into Diabetes Educators’ PracticesBy Nasdaq OMXAug 28, 2017, 1:00 PM UTC
